120 related articles for article (PubMed ID: 16675170)
1. Latin American position on the current status of hormone therapy during the menopausal transition and thereafter.
Maia H; Albernaz MA; Baracat EC; Barbosa IC; Bossemeyer R; Bueno AH; Campos OG; Carranza-Lira S; Casas PF; Castro AM; de Lima GR; de Melo NR; Fernandes CE; González JS; Larrañaga FE; Siseles N; Uribe AM; Vilchez RM; Latin American Expert Panel
Maturitas; 2006 Aug; 55(1):5-13. PubMed ID: 16675170
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2010 Mar; 17(2):242-55. PubMed ID: 20154637
[TBL] [Abstract][Full Text] [Related]
3. When is it appropriate to prescribe postmenopausal hormone therapy?
Ettinger B; Barrett-Connor E; Hoq LA; Vader JP; Dubois RW
Menopause; 2006; 13(3):404-10. PubMed ID: 16735937
[TBL] [Abstract][Full Text] [Related]
4. Clinical guidelines for improving compliance with hormone therapy in Latin American women during the menopausal transition and thereafter.
Maia H; Bossemeyer R; Espinosa-Larrañaga F; Murillo A; Siseles N
Maturitas; 2007 Jan; 56(1):101-9. PubMed ID: 16889912
[TBL] [Abstract][Full Text] [Related]
5. Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.
Skouby SO; Barlow D; Samsioe G; Gompel A; Pines A; Al-Azzawi F; Graziottin A; Hudita D; Rozenberg S;
Maturitas; 2004 May; 48(1):19-25. PubMed ID: 15223104
[TBL] [Abstract][Full Text] [Related]
6. The medical management of menopause: to treat or not to treat?
Barlow DH
Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
[TBL] [Abstract][Full Text] [Related]
7. WHI risks: any relevance to menopause management?
Burger HG
Maturitas; 2007 May; 57(1):6-10. PubMed ID: 17368974
[TBL] [Abstract][Full Text] [Related]
8. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(2):168-82. PubMed ID: 17259911
[TBL] [Abstract][Full Text] [Related]
9. Undertreatment of menopausal symptoms and novel options for comprehensive management.
Lewis V
Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
[TBL] [Abstract][Full Text] [Related]
10. Attitudes towards the menopause and hormone therapy over the turn of the century.
Lindh-Astrand L; Brynhildsen J; Hoffmann M; Liffner S; Hammar M
Maturitas; 2007 Jan; 56(1):12-20. PubMed ID: 16797891
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and cardiovascular disease--still much to be learnt.
Mikkola TS; Ylikorkala O
Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832
[TBL] [Abstract][Full Text] [Related]
12. Treatment for the menopause in Central America: use, knowledge, perceptions and attitudes among urban living middle-aged women.
Tserotas K; Hernandez L; Morera F; Pineda R; Chedraui P
Gynecol Endocrinol; 2011 Jul; 27(7):504-11. PubMed ID: 20626238
[TBL] [Abstract][Full Text] [Related]
13. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
14. Benefits and risks of long-term low-dose oral continuous combined hormone therapy.
van de Weijer PH; Mattsson LA; Ylikorkala O
Maturitas; 2007 Mar; 56(3):231-48. PubMed ID: 17034966
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of hormone therapy in women at high risks of fracture in Sweden, the US and the UK--results based on the Women's Health Initiative randomised controlled trial.
Lekander I; Borgström F; Ström O; Zethraeus N; Kanis JA
Bone; 2008 Feb; 42(2):294-306. PubMed ID: 18053789
[TBL] [Abstract][Full Text] [Related]
16. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
North American Menopause Society
Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
[TBL] [Abstract][Full Text] [Related]
17. Bone health and aging: implications for menopause.
Mirza FS; Prestwood KM
Endocrinol Metab Clin North Am; 2004 Dec; 33(4):741-59. PubMed ID: 15501643
[TBL] [Abstract][Full Text] [Related]
18. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
19. Impact of recent studies on attitudes and use of hormone therapy among Scandinavian gynaecologists.
Pedersen AT; Iversen OE; Løkkegaard E; Mattsson LA; Milsom I; Nilsen ST; Ottesen B; Moen MH
Acta Obstet Gynecol Scand; 2007; 86(12):1490-5. PubMed ID: 18027116
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of postmenopausal hormone therapy.
Grady D; Sawaya GF
Am J Med; 2005 Dec; 118 Suppl 12B():163-5. PubMed ID: 16414343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
